122 related articles for article (PubMed ID: 9438208)
1. Defect in Th1-like cells of nonresponders to hepatitis B vaccine.
Chedid MG; Deulofeut H; Yunis DE; Lara-Marquez ML; Salazar M; Deulofeut R; Awdeh Z; Alper CA; Yunis EJ
Hum Immunol; 1997 Nov; 58(1):42-51. PubMed ID: 9438208
[TBL] [Abstract][Full Text] [Related]
2. Normal HBsAg presentation and T-cell defect in the immune response of nonresponders.
Salazar M; Deulofeut H; Granja C; Deulofeut R; Yunis DE; Marcus-Bagley D; Awdeh Z; Alper CA; Yunis EJ
Immunogenetics; 1995; 41(6):366-74. PubMed ID: 7759133
[TBL] [Abstract][Full Text] [Related]
3. Nonresponders to hepatitis B vaccine can present envelope particles to T lymphocytes.
Desombere I; Hauser P; Rossau R; Paradijs J; Leroux-Roels G
J Immunol; 1995 Jan; 154(2):520-9. PubMed ID: 7814865
[TBL] [Abstract][Full Text] [Related]
4. The cellular basis for lack of antibody response to hepatitis B vaccine in humans.
Egea E; Iglesias A; Salazar M; Morimoto C; Kruskall MS; Awdeh Z; Schlossman SF; Alper CA; Yunis EJ
J Exp Med; 1991 Mar; 173(3):531-8. PubMed ID: 1825504
[TBL] [Abstract][Full Text] [Related]
5. The immune response to hepatitis B vaccine in humans: inheritance patterns in families.
Kruskall MS; Alper CA; Awdeh Z; Yunis EJ; Marcus-Bagley D
J Exp Med; 1992 Feb; 175(2):495-502. PubMed ID: 1531063
[TBL] [Abstract][Full Text] [Related]
6. Complex cytokine responses to hepatitis B surface antigen and tetanus toxoid in responders, nonresponders and subjects naive to hepatitis B surface antigen.
Larsen CE; Xu J; Lee S; Dubey DP; Uko G; Yunis EJ; Alper CA
Vaccine; 2000 Jul; 18(26):3021-30. PubMed ID: 10825606
[TBL] [Abstract][Full Text] [Related]
7. Non-responsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co-stimulation.
Desombere I; Cao T; Gijbels Y; Leroux-Roels G
Clin Exp Immunol; 2005 Apr; 140(1):126-37. PubMed ID: 15762884
[TBL] [Abstract][Full Text] [Related]
8. The antibody response to HBs antigen is regulated by coordinated Th1 and Th2 cytokine production in healthy neonates.
Jafarzadeh A; Shokri F
Clin Exp Immunol; 2003 Mar; 131(3):451-6. PubMed ID: 12605698
[TBL] [Abstract][Full Text] [Related]
9. TH1 and TH2 responses are influenced by HLA antigens in healthy neonates vaccinated with recombinant hepatitis B vaccine.
Jafarzadeh A; Shokri F
Iran J Allergy Asthma Immunol; 2012 Dec; 11(4):308-15. PubMed ID: 23264407
[TBL] [Abstract][Full Text] [Related]
10. Analysis of T-cell receptor beta chain variable gene segment usage in healthy adult responders and nonresponders to recombinant hepatitis B vaccine.
Soroosh P; Shokri F; Azizi M; Jeddi-Tehrani M
Scand J Immunol; 2003 May; 57(5):423-31. PubMed ID: 12753498
[TBL] [Abstract][Full Text] [Related]
11. Enumeration of hepatitis B surface antigen-specific B lymphocytes in responder and non-responder normal individuals vaccinated with recombinant hepatitis B surface antigen.
Shokrgozar MA; Shokri F
Immunology; 2001 Sep; 104(1):75-9. PubMed ID: 11576223
[TBL] [Abstract][Full Text] [Related]
12. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). V. T cell proliferative response and cellular interactions.
Milich DR; Louie RE; Chisari FV
J Immunol; 1985 Jun; 134(6):4194-202. PubMed ID: 3921619
[TBL] [Abstract][Full Text] [Related]
13. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.
Whalen RG; Leclerc C; Dériaud E; Schirmbeck R; Reimann J; Davis HL
Ann N Y Acad Sci; 1995 Nov; 772():64-76. PubMed ID: 8546414
[TBL] [Abstract][Full Text] [Related]
14. Haplotypes comprising subtypes of the DQB1*06 allele direct the antibody response after immunisation with hepatitis B surface antigen.
Langö-Warensjö A; Cardell K; Lindblom B
Tissue Antigens; 1998 Oct; 52(4):374-80. PubMed ID: 9820601
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines.
Desombere I; Gijbels Y; Verwulgen A; Leroux-Roels G
Clin Exp Immunol; 2000 Dec; 122(3):390-9. PubMed ID: 11122245
[TBL] [Abstract][Full Text] [Related]
16. Deficient T-cell responses in non-responders to hepatitis B vaccination: absence of TH1 cytokine production.
Vingerhoets J; Vanham G; Kestens L; Penne G; Leroux-Roels G; Gigase P
Immunol Lett; 1994 Feb; 39(2):163-8. PubMed ID: 8013962
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells.
Akbar SM; Abe M; Masumoto T; Horiike N; Onji M
J Hepatol; 1999 May; 30(5):755-64. PubMed ID: 10365798
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B surface antigen presentation and HLA-DRB1*- lessons from twins and peptide binding studies.
Kruger A; Adams P; Hammer J; Böcher WO; Schneider PM; Rittner C; Hoehler T
Clin Exp Immunol; 2005 May; 140(2):325-32. PubMed ID: 15807858
[TBL] [Abstract][Full Text] [Related]
19. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells.
Bauer T; Günther M; Bienzle U; Neuhaus R; Jilg W
Liver Transpl; 2007 Mar; 13(3):434-42. PubMed ID: 17318860
[TBL] [Abstract][Full Text] [Related]
20. Induction of anti-HBs in HB vaccine nonresponders in vivo by hepatitis B surface antigen-pulsed blood dendritic cells.
Fazle Akbar SM; Furukawa S; Yoshida O; Hiasa Y; Horiike N; Onji M
J Hepatol; 2007 Jul; 47(1):60-6. PubMed ID: 17467112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
